No abstract available
Keywords:
Entamoeba histolytica; adaptation to stress; drug discovery and resistance; metabolism; microbiome; pathogenesis.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amebicides / pharmacology*
-
Anisomycin / pharmacology
-
Asymptomatic Diseases
-
Drug Discovery
-
Dysentery, Amebic / diagnosis
-
Dysentery, Amebic / drug therapy*
-
Dysentery, Amebic / parasitology
-
Dysentery, Amebic / pathology
-
Entamoeba histolytica / drug effects*
-
Entamoeba histolytica / genetics
-
Entamoeba histolytica / metabolism
-
Entamoeba histolytica / pathogenicity
-
Flavonoids / pharmacology
-
Gene Expression Regulation
-
Humans
-
Life Cycle Stages / drug effects*
-
Life Cycle Stages / genetics
-
Metabolic Networks and Pathways / drug effects*
-
Metabolic Networks and Pathways / genetics
-
Metronidazole / pharmacology
-
Piperidines / pharmacology
-
Prodigiosin / pharmacology
-
Protozoan Proteins / antagonists & inhibitors
-
Protozoan Proteins / genetics*
-
Protozoan Proteins / metabolism
-
Pyridines / pharmacology
-
Severity of Illness Index
Substances
-
Amebicides
-
Flavonoids
-
Piperidines
-
Protozoan Proteins
-
Pyridines
-
Metronidazole
-
Anisomycin
-
lonafarnib
-
Prodigiosin